Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

Gregory M. Pontone; Nadeeka Dissanayka; Liana Apostolova; Richard G. Brown; Roseanne Dobkin; Kathy Dujardin; Joseph H. Friedman; Albert F.G. Leentjens; Eric J. Lenze; Laura Marsh; Lynda Mari; Oury Monchi; Irene H. Richard; Anette Schrag; Antonio P. Strafella; Beth Vernaleo; Daniel Weintraub; Zoltan Mari

doi:10.1038/s41531-019-0102-8

Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

Gregory M. Pontone, Nadeeka Dissanayka, Liana Apostolova, Richard G. Brown, Roseanne Dobkin, Kathy Dujardin, Joseph H. Friedman, Albert F.G. Leentjens, Eric J. Lenze, Laura Marsh, Lynda Mari, Oury Monchi, Irene H. Richard, Anette Schrag, Antonio P. Strafella, Beth Vernaleo, Daniel Weintraub, Zoltan Mari

School of Medicine

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Anxiety is a severe problem for at least one-third of people living with Parkinson’s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson’s Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.

Original language	English (US)
Article number	30
Journal	npj Parkinson's Disease
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/s41531-019-0102-8
State	Published - Dec 1 2019

ASJC Scopus subject areas

Neurology
Clinical Neurology
Cellular and Molecular Neuroscience

Access to Document

10.1038/s41531-019-0102-8

Cite this

Pontone, G. M., Dissanayka, N., Apostolova, L., Brown, R. G., Dobkin, R., Dujardin, K., Friedman, J. H., Leentjens, A. F. G., Lenze, E. J., Marsh, L., Mari, L., Monchi, O., Richard, I. H., Schrag, A., Strafella, A. P., Vernaleo, B., Weintraub, D., & Mari, Z. (2019). Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease. npj Parkinson's Disease, 5(1), Article 30. https://doi.org/10.1038/s41531-019-0102-8

Pontone, GM, Dissanayka, N, Apostolova, L, Brown, RG, Dobkin, R, Dujardin, K, Friedman, JH, Leentjens, AFG, Lenze, EJ, Marsh, L, Mari, L, Monchi, O, Richard, IH, Schrag, A, Strafella, AP, Vernaleo, B, Weintraub, D & Mari, Z 2019, 'Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease', npj Parkinson's Disease, vol. 5, no. 1, 30. https://doi.org/10.1038/s41531-019-0102-8

@article{f37c25544ff44918b6204365bf1cc7bf,

title = "Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson{\textquoteright}s disease",

abstract = "Anxiety is a severe problem for at least one-third of people living with Parkinson{\textquoteright}s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson{\textquoteright}s Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.",

author = "Pontone, {Gregory M.} and Nadeeka Dissanayka and Liana Apostolova and Brown, {Richard G.} and Roseanne Dobkin and Kathy Dujardin and Friedman, {Joseph H.} and Leentjens, {Albert F.G.} and Lenze, {Eric J.} and Laura Marsh and Lynda Mari and Oury Monchi and Richard, {Irene H.} and Anette Schrag and Strafella, {Antonio P.} and Beth Vernaleo and Daniel Weintraub and Zoltan Mari",

note = "Publisher Copyright: {\textcopyright} 2019, The Author(s).",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41531-019-0102-8",

language = "English (US)",

volume = "5",

journal = "npj Parkinson's Disease",

issn = "2373-8057",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

AU - Pontone, Gregory M.

AU - Dissanayka, Nadeeka

AU - Apostolova, Liana

AU - Brown, Richard G.

AU - Dobkin, Roseanne

AU - Dujardin, Kathy

AU - Friedman, Joseph H.

AU - Leentjens, Albert F.G.

AU - Lenze, Eric J.

AU - Marsh, Laura

AU - Mari, Lynda

AU - Monchi, Oury

AU - Richard, Irene H.

AU - Schrag, Anette

AU - Strafella, Antonio P.

AU - Vernaleo, Beth

AU - Weintraub, Daniel

AU - Mari, Zoltan

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Anxiety is a severe problem for at least one-third of people living with Parkinson’s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson’s Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.

AB - Anxiety is a severe problem for at least one-third of people living with Parkinson’s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high prevalence and impact on daily life, anxiety is often undiagnosed and untreated. To better address anxiety in PD, future research must improve knowledge about the mechanism of anxiety in PD and address the lack of empirical evidence from clinical trials. In response to these challenges, the Parkinson’s Foundation sponsored an expert meeting on anxiety on June 13th and 14th 2018. This paper summarizes the findings from that meeting informed by a review of the existing literature and discussions among patients, caregivers, and an international, clinician-scientist, expert panel working group. The goal is to provide recommendations to improve our understanding and treatment of anxiety in PD.

UR - http://www.scopus.com/inward/record.url?scp=85078628261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078628261&partnerID=8YFLogxK

U2 - 10.1038/s41531-019-0102-8

DO - 10.1038/s41531-019-0102-8

M3 - Review article

C2 - 31840044

AN - SCOPUS:85078628261

SN - 2373-8057

VL - 5

JO - npj Parkinson's Disease

JF - npj Parkinson's Disease

IS - 1

M1 - 30

ER -

Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this